Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: June 27, 2018
XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 21, 2011
Showing 1-2 of 2
Last Updated: 09/26/2026